OXCCU Raises $28m in Series B Funding to Scale Sustainable Aviation Fuel from Waste Carbon
Backed by global leaders in aviation, energy, and climate investing, OXCCU strengthens its…
LifeSpan Portfolio Company Remedium Signs Landmark Deal with Eli Lilly
NORWALK, Conn., Sept. 23, 2025 /PRNewswire/ -- Lifespan Vision Ventures is pleased…
STARLight Project chosen as the European consortium to take the lead in next-generation Silicon Photonics on 300mm wafers
STARLight Project chosen as the European consortium to take the lead in…
GameChange Solar Featured in The Wall Street Journal on Saudi Arabia’s Solar Expansion
NORWALK, Conn., Sept. 22, 2025 /PRNewswire/ -- The Wall Street Journal recently featured…
Revive Therapeutics Announces Closing of Second Tranche of Private Placement
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…
Altair and Gordon Murray Group Developing Groundbreaking Ultra Lightweight Platform
Collaboration leverages advanced simulation technology to drive innovation in next-generation vehicle design…
Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum
September 12, 2025 07:00 ET | Source: Cullinan Therapeutics, Inc. CAMBRIDGE, Mass.,…
NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimers Disease Program
The $2.5 Million in NIH STTR Phase 2 Grant allows NanoNewron to…
Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
LEHI, Utah, Sept. 4, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage…
Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock
September 02, 2025 21:33 ET | Source: Mineralys Therapeutics, Inc. RADNOR, Pa.,…